0001035443-23-000283.txt : 20231016
0001035443-23-000283.hdr.sgml : 20231016
20231016191708
ACCESSION NUMBER: 0001035443-23-000283
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231012
FILED AS OF DATE: 20231016
DATE AS OF CHANGE: 20231016
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: ALEXANDRIA REAL ESTATE EQUITIES, INC.
CENTRAL INDEX KEY: 0001035443
STANDARD INDUSTRIAL CLASSIFICATION: REAL ESTATE INVESTMENT TRUSTS [6798]
STATE OF INCORPORATION: MD
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38898
FILM NUMBER: 231328236
BUSINESS ADDRESS:
STREET 1: 26 NORTH EUCLID AVENUE
CITY: PASADENA
STATE: CA
ZIP: 91101
BUSINESS PHONE: 6265780777
MAIL ADDRESS:
STREET 1: 26 NORTH EUCLID AVENUE
CITY: PASADENA
STATE: CA
ZIP: 91101
FORMER NAME:
FORMER CONFORMED NAME: ALEXANDRIA REAL ESTATE EQUITIES INC
DATE OF NAME CHANGE: 19970311
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Alexandria Equities No. 7, LLC
CENTRAL INDEX KEY: 0001776437
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38898
FILM NUMBER: 231328234
BUSINESS ADDRESS:
STREET 1: 26 NORTH EUCLID AVENUE
CITY: PASADENA
STATE: CA
ZIP: 91101
BUSINESS PHONE: 626-578-0777
MAIL ADDRESS:
STREET 1: 26 NORTH EUCLID AVENUE
CITY: PASADENA
STATE: CA
ZIP: 91101
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Alexandria Venture Investments, LLC
CENTRAL INDEX KEY: 0001722024
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38898
FILM NUMBER: 231328235
BUSINESS ADDRESS:
STREET 1: 26 NORTH EUCLID AVENUE
CITY: PASADENA
STATE: CA
ZIP: 91101
BUSINESS PHONE: 626-578-0777
MAIL ADDRESS:
STREET 1: 26 NORTH EUCLID AVENUE
CITY: PASADENA
STATE: CA
ZIP: 91101
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Applied Therapeutics Inc.
CENTRAL INDEX KEY: 0001697532
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 545 5TH AVENUE, SUITE 1400
CITY: NEW YORK
STATE: NY
ZIP: 10017
BUSINESS PHONE: 212-220-9319
MAIL ADDRESS:
STREET 1: 545 5TH AVENUE, SUITE 1400
CITY: NEW YORK
STATE: NY
ZIP: 10017
4
1
wk-form4_1697498217.xml
FORM 4
X0508
4
2023-10-12
0
0001697532
Applied Therapeutics Inc.
APLT
0001035443
ALEXANDRIA REAL ESTATE EQUITIES, INC.
26 NORTH EUCLID AVENUE
PASADENA
CA
91101
0
0
1
0
0001722024
Alexandria Venture Investments, LLC
26 NORTH EUCLID AVENUE
PASADENA
CA
91101
0
0
1
0
0001776437
Alexandria Equities No. 7, LLC
26 NORTH EUCLID AVENUE
PASADENA
CA
91101
0
0
1
0
0
Common Stock
2023-10-12
4
J
0
1600000
A
6155077
I
By subsidiary
Common Stock
2023-10-12
4
J
0
1600000
D
778977
I
By subsidiary
Pre-Funded Warrant
0.0001
2023-10-12
4
J
0
615000
A
Common Stock
615000
1500000
I
By subidiary
Pre-Funded Warrant
0.0001
2023-10-12
4
J
0
615000
D
Common Stock
0
0
I
By subsidiary
These shares have been transferred from Alexandria Equities No. 7, LLC ("AE7"), a wholly owned subsidiary of Alexandria Real Estate Equities, Inc. to Alexandria Venture Investments, LLC ("AVI"), an
affiliate of AE7 and another wholly owned subsidiary of Alexandria Real Estate Equities, Inc.
These securities are held directly by Alexandria Venture Investments, LLC ("AVI"), an affiliate of AE7 and another wholly owned subsidiary of Alexandria Real Estate Equities, Inc.
These securities are held directly by Alexandria Equities No. 7, LLC ("AE7"), a wholly owned subsidiary of Alexandria Real Estate Equities, Inc.
The Pre-Funded Warrants are exercisable immediately and will expire five years from the date of issuance. The Pre-Funded Warrants may not be exercised to the extent such exercise would cause the holder (together with its affiliates, any other persons acting as a group together with the holder or any of the holder's affiliates, and any other persons whose beneficial ownership of the Issuer's common stock would or could be aggregated with the holder's for purposes of Section 13(d) or Section 16 of the Securities Exchange Act of 1934, as amended) to beneficially own more than 19.99% of the Issuer's common stock outstanding immediately after giving effect to such exercise.
ALEXANDRIA EQUITIES NO. 7, LLC By: ARE-Special Services, LLC, managing member By: ALEXANDRIA REAL ESTATE EQUITIES, L.P., managing member By: ARE-QRS CORP., general partner By: /s/ Marc E. Binda, Chief Financial Officer and Treasurer
2023-10-13
By: /s/ Marc E. Binda, Chief Financial Officer and Treasurer ALEXANDRIA EQUITIES NO. 7, LLC By: ARE-Special Services, LLC, managing member
2023-10-13
By: ALEXANDRIA REAL ESTATE EQUITIES, L.P., managing member By: ARE-QRS CORP., general partner By: /s/ Marc E. Binda, Chief Financial Officer and Treasurer
2023-10-13